These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15552533)

  • 1. [Assessment of diet therapy effect on blood pressure of obese persons with and without antihypertensive therapy].
    Vasiljević N; Paunović K; Backović D; Jorga J; Ristić G; Plećas D; Stojanović S
    Vojnosanit Pregl; 2004; 61(4):379-85. PubMed ID: 15552533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive effect of diet compared with drug treatment in obese men with mild hypertension.
    Berglund A; Andersson OK; Berglund G; Fagerberg B
    BMJ; 1989 Aug; 299(6697):480-5. PubMed ID: 2507028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of olmesartan vs irbesartan on metabolic parameters and visfatin in hypertensive obese women.
    De Luis DA; Conde R; Gonzalez Sagrado M; Aller R; Izaola O; Perez Castrillon JL; Romero E; Castro MJ
    Eur Rev Med Pharmacol Sci; 2010 Sep; 14(9):759-63. PubMed ID: 21061834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight reduction versus antihypertensive drug therapy in obese men with high blood pressure: effects upon plasma insulin levels and association with changes in blood pressure and serum lipids.
    Fagerberg B; Berglund A; Andersson OK; Berglund G
    J Hypertens; 1992 Sep; 10(9):1053-61. PubMed ID: 1328365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reductions of body weight and blood pressure in obese hypertensive patients treated by diet. A retrospective study.
    Novi RF; Porta M; Lamberto M; Molinatti GM
    Panminerva Med; 1989; 31(1):13-5. PubMed ID: 2726283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orlistat in hypertensive overweight/obese patients: results of a randomized clinical trial.
    Bloch KV; Salles GF; Muxfeldt ES; Da Rocha Nogueira A
    J Hypertens; 2003 Nov; 21(11):2159-65. PubMed ID: 14597860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety comparative evaluation of orlistat and sibutramine treatment in hypertensive obese patients.
    Derosa G; Cicero AF; Murdolo G; Piccinni MN; Fogari E; Bertone G; Ciccarelli L; Fogari R
    Diabetes Obes Metab; 2005 Jan; 7(1):47-55. PubMed ID: 15642075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of sibutramine plus verapamil sustained release/trandolapril combination on blood pressure and metabolic variables in obese hypertensive patients.
    Nakou E; Filippatos TD; Liberopoulos EN; Tselepis AD; Kiortsis DN; Mikhailidis DP; Elisaf MS
    Expert Opin Pharmacother; 2008 Jul; 9(10):1629-39. PubMed ID: 18570597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orlistat improves blood pressure control in obese subjects with treated but inadequately controlled hypertension.
    Bakris G; Calhoun D; Egan B; Hellmann C; Dolker M; Kingma I;
    J Hypertens; 2002 Nov; 20(11):2257-67. PubMed ID: 12409965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative research on obesity hypertension by the comparisons and associations between waist circumference, body mass index with systolic and diastolic blood pressure, and the clinical laboratory data between four special Chinese adult groups.
    Wu O; Leng JH; Yang FF; Yang HM; Zhang H; Li ZF; Zhang XY; Yuan CD; Li JJ; Pan Q; Liu W; Ren YJ; Liu B; Liu QM; Cao CJ
    Clin Exp Hypertens; 2018; 40(1):16-21. PubMed ID: 29083240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a Modest Weight Loss in Normalizing Blood Pressure in Obese Subjects on Antihypertensive Drugs.
    Gilardini L; Redaelli G; Croci M; Conti A; Pasqualinotto L; Invitti C
    Obes Facts; 2016; 9(4):251-8. PubMed ID: 27454447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Simple obesity in children. A study on the role of nutritional factors].
    Weker H
    Med Wieku Rozwoj; 2006; 10(1):3-191. PubMed ID: 16733288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of visceral obesity on blood pressure values in patients with essential hypertension].
    Jovanović A; Laganović M; Dika Z; Kos J; Pećin I
    Lijec Vjesn; 2006; 128(11-12):393-5. PubMed ID: 17212205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure effects of antihypertensive drugs and changes in lifestyle in a Brazilian hypertensive cohort.
    Fuchs FD; Gus M; Moreira WD; Moreira LB; Moraes RS; Rosito GA; Sorucco A; Atanázio P; Machado R
    J Hypertens; 1997 Jul; 15(7):783-92. PubMed ID: 9222947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical profile and management of patients with hypertension and chronic ischemic heart disease according to BMI.
    Barrios V; Escobar C; Calderón A
    Obesity (Silver Spring); 2010 Oct; 18(10):2017-22. PubMed ID: 20134413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in long-term antihypertensive medication requirements. Effects of weight reduction by dietary intervention in overweight persons with mild hypertension.
    Davis BR; Blaufox MD; Oberman A; Wassertheil-Smoller S; Zimbaldi N; Cutler JA; Kirchner K; Langford HG
    Arch Intern Med; 1993 Aug; 153(15):1773-82. PubMed ID: 8333814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dietary fish and weight reduction on ambulatory blood pressure in overweight hypertensives.
    Bao DQ; Mori TA; Burke V; Puddey IB; Beilin LJ
    Hypertension; 1998 Oct; 32(4):710-7. PubMed ID: 9774368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microalbuminuria in essential hypertensives in treatment for hypertension.
    Cruz HM; Cruzera AB; Cruz J
    Rev Hosp Clin Fac Med Sao Paulo; 1997; 52(5):258-62. PubMed ID: 9595780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in glycaemic status do not predict weight loss in response to hypocaloric diets in obese patients.
    de Luis DA; Aller R; Izaola O; Gonzalez Sagrado M; Conde R
    Clin Nutr; 2006 Feb; 25(1):117-22. PubMed ID: 16278036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.